Wikidata

(Q33394575)

English

Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.

scientific article

In more languages

Statements

title
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
author name string
Walter M Stadler
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
David Waterhouse
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
Sreenivasa Nattam
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
Cynthia S Johnson
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
Mary Jane Waddell
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
Christopher J Sweeney
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
Hoosier Oncology Group
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017
page(s)
1525-1530
1 reference
stated in
Europe PubMed Central
PubMed ID
21422406
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33394575&oldid=1970802075"